Enrolling by Invitation
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
NCT06901622
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, China